GaitIQ is a healthcare IT startup specializing in gait analysis through advanced technologies such as computer vision, artificial intelligence (AI), and cloud-based data analytics. Founded in 2017 and headquartered in San Antonio, Texas, GaitIQ aims to integrate kinematic science into clinical practice, offering cost-effective and user-friendly solutions for early detection and monitoring of neurodegenerative diseases.
Key Strategic Focus
GaitIQ's primary objective is to develop accessible tools for healthcare professionals to detect and monitor early signs of neurodegenerative diseases, particularly Alzheimer's Disease (AD). The company focuses on creating software that analyzes gait patterns using standard video recordings, enabling early intervention and personalized treatment plans.
Financials and Funding
In 2020, GaitIQ secured a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH), amounting to $2,493,238. This funding supports the development and validation of their digital gait biomarker platform for preclinical AD detection.
Pipeline Development
GaitIQ is developing a digital platform that utilizes AI and computer vision to analyze gait patterns from simple video recordings. The platform aims to identify specific gait signatures associated with preclinical AD, facilitating early diagnosis and monitoring. Collaborations with institutions like the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio and Southwest Research Institute are integral to this development.
Technological Platform and Innovation
GaitIQ's proprietary technology leverages computer vision and AI to extract clinically relevant spatio-temporal and 3D kinematic data from standard video footage. This approach allows for non-invasive, cost-effective gait analysis without the need for specialized equipment, distinguishing GaitIQ in the field of digital health diagnostics.
Leadership Team
- Rick Morris: Founder, Chief Executive Officer, and Chief Technology Officer. Morris brings expertise in IoT, cloud computing, deep learning, and healthcare IT, guiding GaitIQ's strategic direction and technological innovation.
- Mike Brown: Vice President of Strategy. Brown focuses on strategic planning and business development, contributing to GaitIQ's growth and market positioning.
Competitor Profile
Market Insights and Dynamics: The global gait analysis system market was valued at $1.23 billion in 2024 and is projected to reach $3.3 billion by 2031, growing at a CAGR of 10.59%. This growth is driven by increasing applications in healthcare, sports, and research sectors.
Competitor Analysis: Key competitors in the gait analysis market include:
- ReTiSense: Specializes in wearable sensor technology for gait analysis.
- Dycare: Offers solutions for movement analysis and rehabilitation.
- TSE Systems: Provides comprehensive gait analysis systems for clinical and research applications.
- Zebris Medical: Develops biomechanical measurement systems for gait and motion analysis.
- Noraxon: Offers a range of biomechanical analysis tools, including gait analysis systems.
These companies focus on various aspects of gait analysis, from wearable sensors to comprehensive motion analysis systems, contributing to a competitive landscape in the industry.
Strategic Collaborations and Partnerships
GaitIQ collaborates with the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio and Southwest Research Institute to advance the development of their digital gait biomarker platform. These partnerships enhance GaitIQ's research capabilities and contribute to the validation of their technology.
Operational Insights
GaitIQ's strategic focus on developing a non-invasive, cost-effective gait analysis platform positions the company to address the growing demand for early detection tools in neurodegenerative diseases. By leveraging AI and computer vision, GaitIQ offers a unique solution that differentiates it from competitors relying on specialized equipment or wearable sensors.
Strategic Opportunities and Future Directions
GaitIQ aims to expand its platform's applications beyond Alzheimer's Disease to other neurodegenerative conditions and movement disorders. Future directions include enhancing the platform's capabilities, exploring additional partnerships, and seeking further funding to support research and development efforts.
Contact Information
- Website: gaitiq.com
- Headquarters: San Antonio, Texas, United States
For more information, contact info@gaitiq.com.
